Weak Spots Blight Novartis Third Quarter As New Products Shine

 
• By Alexandra Shimmings
  
Against currency headwinds Novartis affirms group guidance
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Business

More from Scrip